20 related articles for article (PubMed ID: 6389147)
1. Optimising antiemesis in cancer chemotherapy: efficacy of continuous versus intermittent infusion of high dose metoclopramide in emesis induced by cisplatin.
Warrington PS; Allan SG; Cornbleet MA; MacPherson JS; Smyth JF; Leonard RC
Br Med J (Clin Res Ed); 1986 Nov; 293(6558):1334-7. PubMed ID: 3790968
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of high-dose metoclopramide in cancer patients.
McGovern EM; Grevel J; Bryson SM
Clin Pharmacokinet; 1986; 11(6):415-24. PubMed ID: 3542335
[TBL] [Abstract][Full Text] [Related]
3. The efficacy and safety of GR38032F in the prophylaxis of ifosfamide-induced nausea and vomiting.
Green JA; Watkin SW; Hammond P; Griggs J; Challoner T
Cancer Chemother Pharmacol; 1989; 24(2):137-9. PubMed ID: 2525078
[TBL] [Abstract][Full Text] [Related]
4. Does dexamethasone enhance control of acute cisplatin induced emesis by ondansetron?
Smyth JF; Coleman RE; Nicolson M; Gallmeier WM; Leonard RC; Cornbleet MA; Allan SG; Upadhyaya BK; Bruntsch U
BMJ; 1991 Dec; 303(6815):1423-6. PubMed ID: 1837743
[TBL] [Abstract][Full Text] [Related]
5. Antiemetic control and prevention of side effects of anti-cancer therapy with lorazepam or diphenhydramine when used in combination with metoclopramide plus dexamethasone. A double-blind, randomized trial.
Kris MG; Gralla RJ; Clark RA; Tyson LB; Groshen S
Cancer; 1987 Dec; 60(11):2816-22. PubMed ID: 3315176
[TBL] [Abstract][Full Text] [Related]
6. The antiemetic activity of high-dose alizapride and high-dose metoclopramide in patients receiving cancer chemotherapy: a prospective, randomized, double-blind trial.
Joss RA; Galeazzi RL; Bischoff AK; Pirovino M; Ryssel HJ; Brunner KW
Clin Pharmacol Ther; 1986 Jun; 39(6):619-24. PubMed ID: 3519041
[TBL] [Abstract][Full Text] [Related]
7. Antiemetic efficacy of high-dose metoclopramide: randomized trials with placebo and prochlorperazine in patients with chemotherapy-induced nausea and vomiting.
Gralla RJ; Itri LM; Pisko SE; Squillante AE; Kelsen DP; Braun DW; Bordin LA; Braun TJ; Young CW
N Engl J Med; 1981 Oct; 305(16):905-9. PubMed ID: 7024807
[TBL] [Abstract][Full Text] [Related]
8. High-dose versus low-dose metoclopramide in the prevention of cisplatin-induced emesis. A randomized crossover study in patients with ovarian carcinoma.
Onsrud M; Moxnes A; Sollien A; Grande T; Solesvik O
Cancer; 1988 Jun; 61(12):2429-32. PubMed ID: 3365665
[TBL] [Abstract][Full Text] [Related]
9. The role of metoclopramide in acute and delayed chemotherapy induced emesis: a randomised double blind trial.
O'Brien ME; Cullen MH; Woodroffe C; Kelly K; Burman C; Palmer K; Stuart NS; Blackledge GR; Sharpe J
Br J Cancer; 1989 Nov; 60(5):759-63. PubMed ID: 2679853
[TBL] [Abstract][Full Text] [Related]
10. Comparative trials of ondansetron versus metoclopramide in the prevention of acute cisplatin-induced emesis.
Hesketh PJ
Semin Oncol; 1992 Aug; 19(4 Suppl 10):33-40. PubMed ID: 1387248
[TBL] [Abstract][Full Text] [Related]
11. Emesis due to cancer chemotherapy: results of a prospective, randomised, double-blind trial of varying doses of metoclopramide in the management of cis-platinum-induced vomiting.
Allan SG; Cornbleet MA; Lockhart SP; Warrington PS; Leonard RC; Smyth JF
Eur J Cancer Clin Oncol; 1984 Dec; 20(12):1481-4. PubMed ID: 6389147
[TBL] [Abstract][Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
